Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Roivant Sciences Ltd.
(ROIV US)
$39.53
-0.46
1.15%
Ext:
$41.17
+1.64
4.15%
(After Hours ยท 23:02:54 UTC)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Roivant Sciences Ltd.
(ROIV US)
$39.53
-0.46
1.15%
Ext:
$41.17
+1.64
4.15%
(After Hours ยท 23:02:54 UTC)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
ROIV US
โ
Ask AI
ROIV US
โ
Ask AI
Chronological SEC Filings
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(204)
Expand
10-Q
Q2
ended 30 Sept 2026
9 Nov
8-K
Results of Operations and Financial Condition
9 Nov
8-K
Regulation FD Disclosure
21 Oct
8-K
Submission of Matters to a Vote of Security Holders
18 Sep
8-K
Regulation FD Disclosure
8 Sep
8-K
Other Events
28 Aug
8-K
Regulation FD Disclosure
27 Aug
10-Q
Q1
ended 30 Jun 2026
6 Aug
8-K
Results of Operations and Financial Condition
6 Aug
ARS
Annual report to security holders
29 Jul
DEFA14A
Definitive additional materials
29 Jul
DEF 14A
Definitive proxy statement
29 Jul
S-8
Registration statement (employee benefit plan)
20 May
10-K
FY 2026
ended 31 Mar 2026
20 May
8-K
Results of Operations and Financial Condition
20 May
8-K
Results of Operations and Financial Condition
2 Apr
8-K/A
Entry into a Material Definitive Agreement
23 Mar
8-K
Entry into a Material Definitive Agreement
3 Mar
8-K
Regulation FD Disclosure
3 Mar
10-Q
Q3
ended 31 Dec 2025
6 Feb
Ownership Filings
(803)
Expand
Form 144/A
Pulik Richard
05:46PM
Form 144/A
Pulik Richard
05:45PM
Form 4
Torti Frank
12 Nov
Form 4
Gline Matthew
12 Nov
Form 4
Sukhatme Mayukh
12 Nov
Form 4
Pulik Richard
12 Nov
Form 4
Venker Eric
12 Nov
Form 144
Pulik Richard
12 Nov
Form 144/A
Torti Frank
10 Nov
Form 144/A
Gline Matthew
10 Nov
Form 144/A
Sukhatme Mayukh
10 Nov
Form 144
Venker Eric
10 Nov
Form 144
Sukhatme Mayukh
10 Nov
Form 144
Gline Matthew
10 Nov
Form 144
Torti Frank
10 Nov
Form 144
Pulik Richard
10 Nov
Form 4
Venker Eric
5 Nov
SC 13G/A
Roivant Sciences Ltd.
5 Nov
Form 144
Venker Eric
3 Nov
Form 4
Venker Eric
30 Oct
Select Filings
Non-Ownership Filings
(204)
Expand
10-Q
Q2
ended 30 Sept 2026
9 Nov
8-K
Results of Operations and Financial Condition
9 Nov
8-K
Regulation FD Disclosure
21 Oct
8-K
Submission of Matters to a Vote of Security Holders
18 Sep
8-K
Regulation FD Disclosure
8 Sep
8-K
Other Events
28 Aug
8-K
Regulation FD Disclosure
27 Aug
10-Q
Q1
ended 30 Jun 2026
6 Aug
8-K
Results of Operations and Financial Condition
6 Aug
ARS
Annual report to security holders
29 Jul
DEFA14A
Definitive additional materials
29 Jul
DEF 14A
Definitive proxy statement
29 Jul
S-8
Registration statement (employee benefit plan)
20 May
10-K
FY 2026
ended 31 Mar 2026
20 May
8-K
Results of Operations and Financial Condition
20 May
8-K
Results of Operations and Financial Condition
2 Apr
8-K/A
Entry into a Material Definitive Agreement
23 Mar
8-K
Entry into a Material Definitive Agreement
3 Mar
8-K
Regulation FD Disclosure
3 Mar
10-Q
Q3
ended 31 Dec 2025
6 Feb
Ownership Filings
(803)
Expand
Form 144/A
Pulik Richard
05:46PM
Form 144/A
Pulik Richard
05:45PM
Form 4
Torti Frank
12 Nov
Form 4
Gline Matthew
12 Nov
Form 4
Sukhatme Mayukh
12 Nov
Form 4
Pulik Richard
12 Nov
Form 4
Venker Eric
12 Nov
Form 144
Pulik Richard
12 Nov
Form 144/A
Torti Frank
10 Nov
Form 144/A
Gline Matthew
10 Nov
Form 144/A
Sukhatme Mayukh
10 Nov
Form 144
Venker Eric
10 Nov
Form 144
Sukhatme Mayukh
10 Nov
Form 144
Gline Matthew
10 Nov
Form 144
Torti Frank
10 Nov
Form 144
Pulik Richard
10 Nov
Form 4
Venker Eric
5 Nov
SC 13G/A
Roivant Sciences Ltd.
5 Nov
Form 144
Venker Eric
3 Nov
Form 4
Venker Eric
30 Oct
Ask in Filing
Ask in Filing